BioSpace News Archive

Biotech Beach

ImmPACT Bio to Present at Jefferies Cell & Genetic Medicine Summit

ImmPACT Bio USA , Inc. today announced that it will participate at the Jefferies Cell & Genetic Medicine Summit, to be held from September 26 -27, 2023.

September 13, 2023

·

1 min read

Drug Development

J INTS BIO, WCLC 2023 - Presentation of Phase 1/2 study of ‘JIN-A02', a Novel Oral 4th Generation EGFR TKI

J INTS BIO announced that Phase 1/2 study of its novel, orally administered 4th generation EGFR-TKI ‘JIN-A02' was presented at the 2023 IASLC World Conference on Lung Cancer held in Singapore from 9th to 12th September, during the official session entitled “Metastatic Non-small Cell Lung Cancer – Targeted Therapy - EGFR/HER2".

September 13, 2023

·

1 min read

Singleron launches AccuraCode® TCR library construction kit, enhancing efficiency and cost-effectiveness of high-throughput T-cell receptor profiling

Singleron has announced the launch of its AccuraCode® TCR library construction kit for high-throughput T-cell receptor profiling.

September 13, 2023

·

2 min read

BioForest

Adaptive Announces Launch of Epic Integration for clonoSEQ®The Adaptive-Epic integration will provide clinicians and patients with easier access to minimal residual disease (MRD) monitoring in blood cancers

Adaptive Biotechnologies Corporation today announced that clonoSEQ ® is now available to health care providers as a fully integrated test in Aura, Epic’s specialty diagnostics suite.

September 13, 2023

·

6 min read

TerrAscend to Host 2023 Investor Day on October 13th at The Toronto Stock Exchange

TerrAscend Corp. today announced that it will host an Investor Day at the Toronto Stock Exchange (the “TSX”) in Toronto, Ontario, on Friday, October 13, 2023 from 9:30 a.m. to approximately 12:30 p.m. ET.

September 13, 2023

·

2 min read

Pharm Country

PDS Biotech to Host Key Opinion Leader Roundtable Addressing Current and Future Treatments for Recurrent/Metastatic HPV-Positive HNSCC

PDS Biotechnology Corporation today announced it will host a Key Opinion Leader (KOL) Roundtable on Addressing Current and Future Treatments for Recurrent/Metastatic Human Papillomavirus (HPV)-Positive Head and Neck Squamous Cell Carcinoma.

September 13, 2023

·

8 min read

FDA

Insight Medbotics Announces World’s First FDA-Cleared, MRI-Compatible Robot

Insight Medbotics today announced a successful 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the IGAR system, the company’s MRI-compatible robot.

September 13, 2023

·

3 min read

Drug Development

Regulus Therapeutics Announces Completion of Enrollment in Second Cohort of Phase 1b Multiple-Ascending Dose (MAD) Clinical Trial of RGLS8429 for the Treatment of Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Regulus Therapeutics Inc. today announced it has completed enrollment in the second cohort of patients in the ongoing Phase 1b MAD study of RGSL8429 for the treatment of ADPKD.

September 13, 2023

·

5 min read

Pharm Country

HARMONY BIOSCIENCES TO PARTICIPATE IN 2023 CANTOR GLOBAL HEALTHCARE CONFERENCE

Harmony Biosciences Holdings, Inc. today announced that Harmony’s management team will participate in a fireside chat at the upcoming 2023 Cantor Global Healthcare Conference.

September 13, 2023

·

1 min read

Genetown

Takeda Announces FDA Acceptance of BLA for Subcutaneous Administration of ENTYVIO® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Crohn’s Disease

Takeda Announces FDA Acceptance of BLA for Subcutaneous Administration of ENTYVIO ® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Crohn’s Disease.

September 13, 2023

·

14 min read